Dr. Andrew J Weickhardt
Claim this profileAustin Health
Studies Solid Tumors
Studies Head and Neck Cancers
7 reported clinical trials
17 drugs studied
Area of expertise
1Solid Tumors
Stage IV
FGFR positive
2Head And Neck Cancers
Stage IV
Stage III
EGFR positive
Clinical Trials Andrew J Weickhardt is currently running
TAK-186
for Advanced Cancer
This trial is testing a new drug called TAK-186 to see if it is safe and effective for adults with advanced cancers that cannot be removed by surgery. The drug works by targeting a specific protein on cancer cells to help stop their growth.
Recruiting1 award Phase 1 & 210 criteria
AU-007
for Advanced Cancer
This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w). Once the recommended phase 2 dose (RP2D) of AU-007 plus aldesleukin is determined, AU-007 plus aldesleukin will also be administered with avelumab.
Recruiting1 award Phase 1 & 28 criteria
More about Andrew J Weickhardt
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Andrew J Weickhardt has experience with
- Cisplatin
- Etoposide
- Bleomycin Sulfate
- Filgrastim
- Pegfilgrastim
- TAK-186
Breakdown of trials Andrew J Weickhardt has run
Solid Tumors
Head and Neck Cancers
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew J Weickhardt specialize in?
Andrew J Weickhardt focuses on Solid Tumors and Head and Neck Cancers. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are FGFR positive.
Is Andrew J Weickhardt currently recruiting for clinical trials?
Yes, Andrew J Weickhardt is currently recruiting for 3 clinical trials in Heidelberg Victoria. If you're interested in participating, you should apply.
Are there any treatments that Andrew J Weickhardt has studied deeply?
Yes, Andrew J Weickhardt has studied treatments such as Cisplatin, Etoposide, Bleomycin Sulfate.
What is the best way to schedule an appointment with Andrew J Weickhardt?
Apply for one of the trials that Andrew J Weickhardt is conducting.
What is the office address of Andrew J Weickhardt?
The office of Andrew J Weickhardt is located at: Austin Health, Heidelberg, Victoria 3084 Australia. This is the address for their practice at the Austin Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.